title: Targeted Vascular Drug Delivery in Cerebral Cancer.
abstract: This review presents the present-day literature on the anatomy and physiological mechanisms of the blood-brain barrier and the problematic of cerebral drug delivery in relation to malignant brain tumors. First step in treatment of malignant brain tumors is resection, but there is a high risk of single remnant infiltrative tumor cells in the outer zone of the brain tumor. These infiltrative single-cells will be supplied by capillaries with an intact BBB as opposed to the partly leaky BBB found in the tumor tissue before resection. Even though BBB penetrance of a chemotherapeutic agent is considered irrelevant though the limited success rate for chemotherapeutic treatability of GBM tumors indicate otherwise. Therefore drug delivery strategies to cerebral cancer after resection should be tailored to being able to both penetrate the intact BBB and target the cancer cells. In this review the intact bloodbrain barrier and cerebral cancer with main focus on glioblastoma multiforme (GBM) is introduced. The GBM induced formation of a blood-tumor barrier and the consequences hereof is described and discussed with emphasis on the impact these changes of the BBB has on drug delivery to GBM. The most commonly used drug carriers for drug delivery to GBM is described and the current drug delivery strategies for glioblastoma multiforme including possible routes through the BBB and epitopes, which can be targeted on the GBM cells is outlined. Overall, this review aims to address targeted drug delivery in GBM treatment when taking the differing permeability of the BBB into consideration.
authors.forename: Nanna
authors.initials: N
authors.lastname: Humle
authors.forename: Kasper Bendix
authors.initials: KB
authors.lastname: Johnsen
authors.forename: Gitte Abildgaard
authors.initials: GA
authors.lastname: Arendt
authors.forename: Rikke Paludan
authors.initials: RP
authors.lastname: Nielsen
authors.forename: Torben
authors.initials: T
authors.lastname: Moos
authors.affiliation: Laboratory for Neurobiology, Biomedicine Group, Department of Health Science and Technology, Fr. Bajers Vej 3B, 1.216, Aalborg University, DK-9220 Aalborg East, Denmark. lbt@hst.aau.dk.
authors.forename: Louiza Bohn
authors.initials: LB
authors.lastname: Thomsen
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology*; D001812:Blood-Brain Barrier / Q000187:drug effects / Q000473:pathology; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016503:Drug Delivery Systems; D005909:Glioblastoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans
chemical_list: D000970:Antineoplastic Agents